Antimetastatic and Immunomodulating Effect of Water Extracts From Various Mushrooms

Abbas, 1997, 253 Lee, 2003, Antimetastatic and immunomodulating properties of a new herbal prescription, Bojung-bangam-tang. Int Immunopharmacol, 3, 147, 10.1016/S1567-5769(02)00091-7 Harada, 1995, Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang), Immunopharmacol Immunotoxicol, 17, 687, 10.3109/08923979509037189 Ohnishi, 1998, Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells, Jpn J Cancer Res, 89, 206, 10.1111/j.1349-7006.1998.tb00550.x Borchers, 1999, Mushrooms, tumors and immunity, Proc Soc Exp Biol Med, 221, 281, 10.3181/00379727-221-44412 Kim, 2002, Dietary factors and gastric cancer in Korea: a case-control study, Int J Cancer, 97, 531, 10.1002/ijc.10111 Zaidman, 2005, Medicinal mushroom modulators of molecular targets as cancer therapeutics, Appl Microbiol Biotechnol, 67, 453, 10.1007/s00253-004-1787-z deVere White, 2002, Effects of a mushroom mycelium extract on the treatment of prostate cancer, Urology, 60, 640, 10.1016/S0090-4295(02)01856-3 Chang, 1996, Functional properties of edible mushrooms, Nutr Rev, 54, 9193 1990 Chen, 1997, Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells, Life Sci, 60, 2349, 10.1016/S0024-3205(97)00291-9 Fujimiya, 1999, Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete, Agaricus blazeiu Murill, Anticancer Res, 19, 113 Chen, 1997, Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells, Life Sci, 60, 2349, 10.1016/S0024-3205(97)00291-9 Zhang, 2004, Effects of Chinese medicinal fungus water extract on tumor metastasis and some parameters of immune function, Int Immunopharmacol, 4, 461, 10.1016/j.intimp.2004.01.014 Borchers, 2004, Mushrooms, tumors, and immunity: an update, Exp Biol Med (Maywood), 229, 393, 10.1177/153537020422900507 Wasser, 2002, Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides, Appl Microbiol Biotechnol, 60, 258, 10.1007/s00253-002-1076-7 Sagar, 2007, Coriolus versicolor extracts: relevance in cancer management, Curr Oncol, 14, 41 Donald, 2009, 130 Park, 2004, Effects of Armillaria mellea extract on macrophage and NK cell activity, Korean J Oriental Med, 25, 161 Kodama, 2003, Effect of Maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients, J Med Food, 6, 371, 10.1089/109662003772519949 Mizuno, 1986, Fractionation and characterization of antitumor polysaccharides from Maitake, Grifola frondosa, Agric Biol Chem, 50, 1679, 10.1271/bbb1961.50.1679 Ohno, 1986, Characterization of the antitumor glucan obtained from liquid cultured Grifola frondosa, Chem Pharm Bull, 34, 1709, 10.1248/cpb.34.1709 Shigesue, 2000, Effects of maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice, Jpn J Pharmacol, 84, 293, 10.1254/jjp.84.293 Czop, 1991, Isolation and characterization of β-glucan receptors on human mononuclear phagocytes, J Exp Med, 173, 1511, 10.1084/jem.173.6.1511 Tabata, 1981, Ultrasonic degradation of schizophyllan, an antitumor polysaccharide produced by Schizophyllum commune Fries, Carbohydr Res, 89, 121, 10.1016/S0008-6215(00)85234-9 Yanaki, 1983, Correlation between the antitumor activity of a polysaccharide schizophyllan and its triple-helical conformation in dilute aqueous solution, Biophys Chem, 17, 337, 10.1016/0301-4622(83)80018-0 Lee, 2006, Induction of apoptosis by Cordyceps militaris through activation of caspase-3 in leukemia HL-60 cells, Biol Pharm Bull, 29, 670, 10.1248/bpb.29.670 Yoo, 2004, Effects of Cordyceps militaris extract on angiogenesis and tumor growth, Acta Pharmacol Sin, 25, 657 Mizuno, 1992, Antitumor active polysaccharides isolated from the fruiting body of Hericium erinaceum, an edible and medicinal mushroom called yamabushitake or houtou, Biosci Biotechnol Biochem, 56, 347, 10.1271/bbb.56.347 Stadler, 1994, Fatty acids and other compounds with nematicidal activity from cultures of Basidiomycetes, Planta Med, 60, 128, 10.1055/s-2006-959433 Son, 2006, Macrophage activation and nitric oxide production by water soluble components of Hericium erinaceum, Int Immunopharmacol, 6, 1363, 10.1016/j.intimp.2006.03.005 Son, 2006, Induction of murine interleukin-1 beta expression by water soluble components from Hericium erinaceum, Acta Pharmacol Sin, 27, 1058, 10.1111/j.1745-7254.2006.00321.x Lin, 2004, Antitumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms, Acta Pharmacol Sin, 25, 1387 Cui, 2003, Polysaccharopeptides of Coriolus versicolor : physiological activity, uses, and production, Biotechnol Adv, 21, 109, 10.1016/S0734-9750(03)00002-8 Fisher, 2002, Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy, Anticancer Res, 22, 1737 Ebina, 1986, Antimetastatic effect of biological response modifiers in “double grafted tumor system”, Jpn J Cancer Res, 77, 1034 Fujimiya, 1998, Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis, Cancer Immunol Immunother, 46, 147, 10.1007/s002620050473 Itoh, 1994, Inhibitory action of α (1→6)-beta-D-glucan-protein complex (FIII-2-b) isolated from Agaricus blazei Murill (“himematsutake”) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism, Jpn J Pharmacol, 66, 265, 10.1254/jjp.66.265 Mizuno, 1998, Polysac charides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice, Biosci Biotechnol Biochem, 62, 434, 10.1271/bbb.62.434 Mizuno, 1999, Antitumor polysaccharide from the mycelium of liquidcultured Agaricus blazei mil, Biochem Mol Biol Int, 47, 707 Gan, 2003, A polysaccharideprotein complex from Lyciumbarbarum upregulates cytokine expression in human peripheral blood mononuclearcells, Eur J Pharmacol, 471, 217, 10.1016/S0014-2999(03)01827-2 Gan, 2004, Immunomodulation and antitumor activity by a polysaccharideprotein complex from Lycium barbarum, Int Immunopharmacol, 4, 563, 10.1016/j.intimp.2004.01.023 Ha, 2005, Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity, J Ethnopharmacol, 96, 529, 10.1016/j.jep.2004.09.054 Gong, 2005, Therapeutic effects of Lycium barbarum polysaccharide (LBP) on irradiation or chemotherapy-induced myelosuppressive mice, Cancer Biother Radiopharm, 20, 155, 10.1089/cbr.2005.20.155 Gong, 2004, Therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C (MMC)-induced myelosuppressive mice, J Exp Ther Oncol, 4, 181 Zhang, 2005, Effect of Lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis, Life Sci, 76, 2115, 10.1016/j.lfs.2004.11.009 Chao, 2006, Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepato-cellular carcinoma cells, World J Gastroenterol, 12, 4478, 10.3748/wjg.v12.i28.4478 Chen, 2008, Activation of T lymphocytes by polysaccharideprotein complex from Lycium barbarum L, Int Immunopharmacol, 8, 1663, 10.1016/j.intimp.2008.07.019 Zola, 2005, CD molecules 2005: human cell differentiation molecules, Blood, 106, 3123, 10.1182/blood-2005-03-1338 Fiebig, 1984, Characterization of a series of monoclonal antibodies against human T cells, Allerg Immunol (Leipz), 30, 242 Miceli, 1993, Role of CD4 and CD8 in T cell activation and differentiation, Adv Immunol, 53, 59, 10.1016/S0065-2776(08)60498-8 Goldsby, 2007 Nakamori, 2003, Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer, Clin Cancer Res, 9, 2357 Nishimura, 1999, Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo, J Exp Med, 190, 617, 10.1084/jem.190.5.617 Mosmann, 1996, The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol Today, 17, 138, 10.1016/0167-5699(96)80606-2 Featon, 1990, Interleukin 2 production by tumor bypasses T-helper function in the generation of an anti-tumor response, Cell, 60, 397, 10.1016/0092-8674(90)90591-2 Tepper, 1989, Murine interleukin-4 displays potent anti-tumor activity in vivo, Cell, 57, 503, 10.1016/0092-8674(89)90925-2 Allione, 1994, Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with IL-2, IL-4, IL-6, IL-7, IL-10, TNF-α, GM-CSF, and IFN-γ gene or admixed with conventional adjuvants, Cancer Res, 54, 6022 Shen, 1996, A tumor-specific Th2 clone initiating tumor rejection via primed CD8+ cytotoxic T-lymphocyte activation in mice, Cancer Res, 56, 5005 Obiri, 1993, Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4, J Clin Invest, 91, 88, 10.1172/JCI116205 Bosco, 1990, Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory, J Immunol, 145, 3136, 10.4049/jimmunol.145.9.3136